ADVERTISEMENT
Posted: Jun 7, 2025

Pharmacist-led diabetes management improves outcomes and lowers costs

Diabetes Management

More than 38 million adults in the United States have diabetes, with the highest prevalence among people of color.

Sonya Collins

Read more
Posted: Jun 7, 2025

Research provides clarity on how steroid dose and timing influence leukocytosis

Corticosteroids

Corticosteroids, widely used in inpatient settings to manage inflammation, are known to elevate white blood cell counts, but the extent and timing of that effect have remained poorly defined.

Aiya Almogaber, PharmD

Read more
Posted: Jun 7, 2025

Oral semaglutide offers cardiovascular benefits in high-risk T2D

Heart Health

Last year, FDA approved injectable semaglutide (Wegovy) to reduce the risk of cardiovascular death, heart attack, and stroke in people with CVD and obesity or overweight.

Sonya Collins

Read more
Posted: Jun 7, 2025

Study findings suggest DOACs are favorable treatment option for CVT

Anticoagulation

Comparing outcomes between direct oral anticoagulant (DOAC) and vitamin K antagonist users across a large, multinational cohort, researchers found no significant differences in rates of major bleeding or recurrent thrombosis.

Corey Diamond, PharmD

Read more
Posted: Jun 7, 2025

Naltrexone for alcohol use disorder may work for hospitalized patients

Naltrexone

Naltrexone has been a successful treatmeant for alcohol use disorder and other related disorders for a long time. However, its popularity has come against a backdrop of lingering questions: Is extended-release injectable naltrexone or daily oral naltrexone more effective?

Deborah Russell-Brown

Read more
1345678910Last

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT